Hu G - Search Results

1

Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma.

Wang H, Feng J, Liu Y, Qian Z, Gao D, Ran X, Zhou H, Liu L, Wang B, Fang M, Zhou H, Huang Z, Tao S, Chen Z, Su L, Su H, Yang Y, Xie X, Wu H, Sun P, Hu G, Liang A, Li Z. Wang H, et al. Among authors: hu g. Signal Transduct Target Ther. 2024 Apr 17;9(1):99. doi: 10.1038/s41392-024-01798-0. Signal Transduct Target Ther. 2024. PMID: 38627366 Free PMC article. Clinical Trial.

2

A phase I dose-escalation study of neoantigen-activated haploidentical T cell therapy for the treatment of relapsed or refractory peripheral T-cell lymphoma.

Chen Y, Zhao H, Luo J, Liao Y, Dan X, Hu G, Gu W. Chen Y, et al. Among authors: hu g. Front Oncol. 2022 Nov 10;12:944511. doi: 10.3389/fonc.2022.944511. eCollection 2022. Front Oncol. 2022. PMID: 36439517 Free PMC article.

3

Diagnosis and treatment of multiple myeloma in Hunan Province.

Liu F, Cheng Q, Song K, Yu H, Li J, Zhang H, Hu G, Zhou M, Wang J, Ding Z, Luo Z, Peng T, Ding L, Zhao L, Liu J, He Y, Peng H. Liu F, et al. Among authors: hu g. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Apr 28;47(4):497-504. doi: 10.11817/j.issn.1672-7347.2022.210555. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 35545345 Free PMC article. Chinese, English.

4

[Preliminary Study on the Relationship between the Developmental Stage of Multiple Myeloma Disease and the Results of Bone Marrow Whole Exome Sequencing].

Li QZ, Zhao H, Chen HM, Huang H, Peng J, Hu GY, Shen CJ, Yuan ZH. Li QZ, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Dec;31(6):1750-1756. doi: 10.19746/j.cnki.issn.1009-2137.2023.06.023. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023. PMID: 38071056 Chinese.

5

[Expression and Significance of PD-1, PD-L1 and CTLA-4 in the Bone Marrow of Patients with Multiple Myeloma].

Li QZ, Peng J, Chen HM, Chen ZZ, Zhu ZW, Li LS, Hu GY, Yuan ZH. Li QZ, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Dec;30(6):1803-1809. doi: 10.19746/j.cnki.issn.1009-2137.2022.06.027. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022. PMID: 36476907 Chinese.

6

A small molecular compound CC1007 induces cross-lineage differentiation by inhibiting HDAC7 expression and HDAC7/MEF2C interaction in BCR-ABL1^- pre-B-ALL.

Wang Z, Zhang Y, Zhu S, Peng H, Chen Y, Cheng Z, Liu S, Luo Y, Li R, Deng M, Xu Y, Hu G, Chen L, Zhang G. Wang Z, et al. Among authors: hu g. Cell Death Dis. 2020 Sep 10;11(9):738. doi: 10.1038/s41419-020-02949-1. Cell Death Dis. 2020. PMID: 32913188 Free PMC article.

7

A drug targeting 5-lipoxygenase enhances the activity of a JAK2 inhibitor in CD34⁺ bone marrow cells from patients with JAK2V617F-positive polycythemia vera in vitro.

Chen Y, Zhao H, Luo J, Liao Y, Tan K, Hu G. Chen Y, et al. Among authors: hu g. Oncol Lett. 2021 May;21(5):351. doi: 10.3892/ol.2021.12612. Epub 2021 Mar 4. Oncol Lett. 2021. PMID: 33747208 Free PMC article.

8

A novel germline HAVCR2 (TIM-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in EBV-positive peripheral T-cell lymphoma (NOS) with down-regulated TIM-3 signaling.

Zhang Y, Wang Z, Hu G, Li J, Chen Y, Jiang Y, Zhong H, Liu X, Hu C, Peng H, Xu Y, Cheng Z, Zhang G. Zhang Y, et al. Among authors: hu c, hu g. Front Oncol. 2022 Sep 23;12:870676. doi: 10.3389/fonc.2022.870676. eCollection 2022. Front Oncol. 2022. PMID: 36212426 Free PMC article.

9

CHST15 gene germline mutation is associated with the development of familial myeloproliferative neoplasms and higher transformation risk.

Chen Y, Zhang Y, Wang Z, Wang Y, Luo Y, Sun N, Zheng S, Yan W, Xiao X, Liu S, Li J, Peng H, Xu Y, Hu G, Cheng Z, Zhang G. Chen Y, et al. Among authors: hu g. Cell Death Dis. 2022 Jul 7;13(7):586. doi: 10.1038/s41419-022-05035-w. Cell Death Dis. 2022. PMID: 35798703 Free PMC article.

10

Neoantigen-activated haploidentical T cell therapy for angioimmunoblastic T-cell lymphoma.

Chen Y, Chen H, Gu W, Hu G. Chen Y, et al. Among authors: hu g. Clin Immunol. 2020 Jan;210:108296. doi: 10.1016/j.clim.2019.108296. Epub 2019 Nov 2. Clin Immunol. 2020. PMID: 31689517 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,239 results

Search Page